BEAM-alemtuzumab reduced-intensity allogeneic stem cell transplantation for lymphoproliferative diseases: GVHD, toxicity, and survival in 65 patients

R D Faulkner, C Craddock, J L Byrne, P Mahendra, A P Haynes, H G Prentice, M Potter, A Pagliuca, A Ho, S Devereux, G McQuaker, G Mufti, J L Yin, N H Russell

Research output: Contribution to journal › Article › peer-review

167 Citations (Scopus)

Fingerprint

Dive into the research topics of 'BEAM-alemtuzumab reduced-intensity allogeneic stem cell transplantation for lymphoproliferative diseases: GVHD, toxicity, and survival in 65 patients'. Together they form a unique fingerprint.

Medicine and Dentistry

Immunology and Microbiology